Literature DB >> 15886155

An HIV vaccine: as we build it, will they come?

Margaret M McCluskey1, Sarah B Alexander, Brenda D Larkin, Matthew Murguia, Steven Wakefield.   

Abstract

Early researchers accurately predicted that AIDS would have a globally destructive impact. However, other experts erroneously believed that they would be able to develop a vaccine against the virus in a relatively short period. More than twenty years later, scientists continue to work to achieve this goal. This paper addresses the unique obstacles faced by HIV vaccine researchers. It concludes with recommendations for how policymakers and public health officials could collaborate with researchers to overcome these obstacles and contribute to the discovery of an HIV vaccine that would save millions of lives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886155     DOI: 10.1377/hlthaff.24.3.643

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

1.  Demand forecasting for preventive AIDS vaccines: economic and policy dimensions.

Authors:  Robert Hecht; Gian Gandhi
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Bridging the divide: HIV prevention research and Black men who have sex with men.

Authors:  Michele Peake Andrasik; Christian Chandler; Borris Powell; Damon Humes; Steven Wakefield; Katharine Kripke; Daniel Eckstein
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

3.  Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Muhammad Bakari; Joachim Mwami; Eric Sandström; Asli Kulane
Journal:  Glob Health Action       Date:  2009-08-07       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.